These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23321468)

  • 1. An updated meta-analysis of XRCC4 polymorphisms and cancer risk based on 31 case-control studies.
    Shao N; Jiang WY; Qiao D; Zhang SG; Wu Y; Zhang XX; Hua LX; Ding Y; Feng NH
    Cancer Biomark; 2012-2013; 12(1):37-47. PubMed ID: 23321468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.
    Chang CH; Chang CL; Tsai CW; Wu HC; Chiu CF; Wang RF; Liu CS; Lin CC; Bau DT
    Anticancer Res; 2009 May; 29(5):1777-82. PubMed ID: 19443403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients.
    Chiu CF; Tsai MH; Tseng HC; Wang CL; Wang CH; Wu CN; Lin CC; Bau DT
    Oral Oncol; 2008 Sep; 44(9):898-902. PubMed ID: 18164646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
    Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
    Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer susceptibility and genetic polymorphism of DNA repair gene XRCC4 in Taiwan.
    Hsu NY; Wang HC; Wang CH; Chang CL; Chiu CF; Lee HZ; Tsai CW; Bau DT
    Cancer Biomark; 2009; 5(4):159-65. PubMed ID: 19729825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The study of esophageal cancer risk associated with polymorphisms of DNA damage repair genes XRCC4 and RAD51].
    Fan XJ; Ren PL; Lu ZJ; Zhao S; Yang XL; Liu J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):568-72. PubMed ID: 24059110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 polymorphisms and prostate cancer risk: a meta-analysis.
    Shao N; Xu B; Mi YY; Hua LX
    Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):129-35. PubMed ID: 21339768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan.
    Tseng HC; Tsai MH; Chiu CF; Wang CH; Chang NW; Huang CY; Tsai CW; Liang SY; Wang CL; Bau DT
    Anticancer Res; 2008; 28(3A):1687-91. PubMed ID: 18630527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of functional polymorphisms of the XRCC4 gene with the risk of breast cancer: a meta-analysis.
    Zhou LP; Luan H; Dong XH; Jin GJ; Ma DL; Shang H
    Asian Pac J Cancer Prev; 2012; 13(7):3431-6. PubMed ID: 22994773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant association of XRCC4 single nucleotide polymorphisms with childhood leukemia in Taiwan.
    Wu KH; Wang CH; Yang YL; Peng CT; Lin WD; Tsai FJ; Lin DT; Bau DT
    Anticancer Res; 2010 Feb; 30(2):529-33. PubMed ID: 20332465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer and genetic polymorphism of DNA double-strand break repair gene XRCC4 in Taiwan.
    Bau DT; Yang MD; Tsou YA; Lin SS; Wu CN; Hsieh HH; Wang RF; Tsai CW; Chang WS; Hsieh HM; Sun SS; Tsai RY
    Anticancer Res; 2010 Jul; 30(7):2727-30. PubMed ID: 20683005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The
    Zhang XY; Wei XH; Wang BJ; Yao J
    J Int Med Res; 2020 Jun; 48(6):300060520926364. PubMed ID: 32493081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant association of XRCC4 single nucleotide polymorphisms with prostate cancer susceptibility in Taiwanese males.
    Chang CH; Chiu CF; Wu HC; Tseng HC; Wang CH; Lin CC; Tsai CW; Liang SY; Wang CL; Bau DT
    Mol Med Rep; 2008; 1(4):525-30. PubMed ID: 21479444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.
    Tang Z; Nie ZL; Pan Y; Zhang L; Gao L; Zhang Q; Qu L; He B; Song G; Zhang Y; Shukui Wang
    Mutagenesis; 2011 Nov; 26(6):729-34. PubMed ID: 21734230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan.
    Yen CY; Liu SY; Chen CH; Tseng HF; Chuang LY; Yang CH; Lin YC; Wen CH; Chiang WF; Ho CH; Chen HC; Wang ST; Lin CW; Chang HW
    J Oral Pathol Med; 2008 May; 37(5):271-7. PubMed ID: 18410587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
    Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
    Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for XRCC4 in age at diagnosis and breast cancer risk.
    Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
    Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
    Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.
    Yu KD; Chen AX; Yang C; Qiu LX; Fan L; Xu WH; Shao ZM
    Breast Cancer Res Treat; 2010 Jul; 122(1):251-7. PubMed ID: 20033767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies.
    Gu D; Wang M; Wang M; Zhang Z; Chen J
    Mutagenesis; 2009 Nov; 24(6):507-12. PubMed ID: 19762350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.